Terbutaline sulfate and Encephalopathy - a phase IV clinical study of FDA data

Summary:

Encephalopathy is reported as a side effect among people who take Terbutaline sulfate (terbutaline sulfate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Paxil Cr, and have Depression.

The phase IV clinical study analyzes which people have Encephalopathy when taking Terbutaline sulfate. It is created by eHealthMe based on reports of 2,731 people who have side effects when taking Terbutaline sulfate from the FDA, and is updated regularly.

What is Terbutaline sulfate?

Terbutaline sulfate has active ingredients of terbutaline sulfate. It is often used in asthma. eHealthMe is studying from 2,777 Terbutaline sulfate users. Check the latest studies of Terbutaline sulfate.

What is Encephalopathy?

Encephalopathy (functioning of the brain is affected by some agent or condition) is found to be associated with 1,459 drugs and 1,607 conditions by eHealthMe. Check the latest studies of Encephalopathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

2,731 people reported to have side effects when taking Terbutaline sulfate.
Among them, 30 people (1.1%) have Encephalopathy.

Could Terbutaline sulfate cause Encephalopathy?

Among these 30 people:

How long have people been on Terbutaline sulfate when they have Encephalopathy? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Encephalopathy when taking Terbutaline sulfate? *

  • female: 43.33 %
  • male: 56.67 %

What is the age of people who have Encephalopathy when taking Terbutaline sulfate? *

  • 0-1: 0.0 %
  • 2-9: 14.29 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 42.86 %
  • 60+: 42.86 %

What are other drugs people take besides Terbutaline sulfate? *

  1. Hydroxyzine Pamoate: 11 people, 36.67%
  2. Zithromax: 11 people, 36.67%
  3. Paxil Cr: 11 people, 36.67%
  4. Paxil: 9 people, 30.00%
  5. Furosemide: 8 people, 26.67%
  6. Depakote: 8 people, 26.67%
  7. Ipratropium Bromide: 7 people, 23.33%
  8. Cefzil: 6 people, 20.00%
  9. Morphine: 6 people, 20.00%
  10. Anafranil: 6 people, 20.00%

What are other side effects people have besides Encephalopathy? *

  1. Drug Exposure During Pregnancy: 20 people, 66.67%
  2. Developmental Delay: 20 people, 66.67%
  3. Pain: 11 people, 36.67%
  4. Apnea (temporary absence or cessation of breathing): 11 people, 36.67%
  5. Lung Hyperinflation (inspiration of more than normal): 11 people, 36.67%
  6. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina): 11 people, 36.67%
  7. Joint Range Of Motion Decreased (disease of joint movement): 11 people, 36.67%
  8. Hypotonia (low muscle tone): 11 people, 36.67%
  9. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 11 people, 36.67%
  10. Camptodactyly Acquired (camptodactyly refers to congenital or acquired permanent flexion contractures of the fingers): 11 people, 36.67%

What are the existing conditions these people have? *

  1. Depression: 20 people, 66.67%
  2. Infection: 3 people, 10.00%
  3. Prostatic Adenoma (prostatic non-cancerous tumour): 2 people, 6.67%
  4. Dyslipidaemia (abnormal amount of lipids): 2 people, 6.67%
  5. Stress And Anxiety: 1 person, 3.33%
  6. Pain: 1 person, 3.33%
  7. Lung Disorder (lung disease): 1 person, 3.33%
  8. Intervertebral Discitis (infection in the intervertebral disc space): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Terbutaline sulfate and have Encephalopathy?

- Check whether Encephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Terbutaline sulfate:

Encephalopathy treatments and more:

How severe was Encephalopathy and when was it recovered:

Expand to all the drugs that have ingredients of terbutaline sulfate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Terbutaline sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalopathy:

Browse all the conditions that are associated with Encephalopathy:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on terbutaline sulfate (the active ingredients of Terbutaline sulfate) and Terbutaline sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: